# PharmaCyte Biotech, Inc.: Form 8-K, filed Aug 2, 2021

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2021-08-02
- Accepted by EDGAR: Aug 2, 2021, 17:12 ET
- Period: 2021-08-02
- Accession: 0001683168-21-003222
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316821003222/pharma_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316821003222/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316821003222/pharma_8k.htm

Filed Aug 2, 2021.
Source: SEC EDGAR, the filing index for accession 0001683168-21-003222. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
